Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

July 31, 2010

Conditions
Seasonal Influenza
Interventions
BIOLOGICAL

Seasonal flu vaccine

This phase II is performed as a multicenters study site in elderly subjects. Enrolled subjects received one single IM dose of trivalent subunit inactivated adjuvanted flu vaccine during the vaccination visit, according to the study protocol (follow-up period: till day 22)

Trial Locations (6)

16132

Dipartimento di Scienze della Salute Università di Genova Via Pastore, 1, Genova

20127

Vaccine and Immunotherapy Research Center Department of Infectious and Tropical Diseases San Raffaele Scientific Institute Via Stamira d'Ancona, 20, Milan

44100

Dipartimento di Medicina Clinica e Sperimentale - Sezione di Igiene e Medicina Preventiva, Via Fossato di Mortara, 64/b, Ferrara

66034

Centro Satellite. ASL Lanciano - Vasto, sede legale Via S. Spaventa, 37, Lanciano

66100

Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio, Via dei Vestini, Chieti

Unknown

Centro Satellite. Distretto Sanitario di Base di Fossacesia in Via Polidoro-Vasto, Lanciano

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY